Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells
2006 · Oncogene · 167 citations
https://doi.org/10.1038/sj.onc.1210084
T
Tatsu Shimoyama
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
2.9K
Citations
25
h-index
38
i10-index
Tatsu Shimoyama is an academic researcher from Tokyo Metropolitan Komagome Hospital. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Lung Cancer Treatments and Mutations. The author has an h-index of 25, co-authored 123 publications.
Papers by this author
worksTrastuzumab Deruxtecan in Anti–Human Epidermal Growth Factor Receptor 2 Treatment–Naive Patients With Human Epidermal Growth Factor Receptor 2–Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial
2022 · Journal of Clinical Oncology · 108 citations
https://doi.org/10.1200/jco.22.00575
Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer
2022 · Communications Biology · 48 citations
https://doi.org/10.1038/s42003-021-02937-x
Chemotherapy-Regulated microRNA-125–HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer
2015 · Molecular Cancer Therapeutics · 26 citations
https://doi.org/10.1158/1535-7163.mct-14-0625
Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma
2015 · Scientific Reports · 24 citations
https://doi.org/10.1038/srep17868
Selection bias due to delayed comprehensive genomic profiling in Japan
2022 · Cancer Science · 20 citations
https://doi.org/10.1111/cas.15651
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat